First Look Analysts Research Calls for Monday, December 19

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> American Equity Investment Life (AEL) upgraded to Strong Buy from Outperform at Raymond James; tgt $48

> Enphase Energy (ENPH) upgraded to Outperform from Market Perform at Northland Capital; tgt $365

> Glaukos (GKOS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $42

> Moderna (MRNA) upgraded to Buy from Hold at Jefferies; tgt raised to $275

> Pentair (PNR) upgraded to Buy from Hold at Stifel

> PerkinElmer (PKI) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $170

> Verizon (VZ) upgraded to Market Perform from Underperform at MoffettNathanson; tgt $41

Downgrades:

> Ameriprise Financial (AMP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $325

> AT&T (T) downgraded to Underperform from Market Perform at MoffettNathanson; tgt $17

> AXIS Capital (AXS) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $60

> Baxter (BAX) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $55

> Catalent (CTLT) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets

> L3Harris (LHX) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $241

> Louisiana-Pacific (LPX) downgraded to Hold from Buy at TD Securities; tgt $72

> Tesla (TSLA) downgraded to Perform from Outperform at Oppenheimer

> Vertex Pharma (VRTX) downgraded to Hold from Buy at Jefferies; tgt $340

> VTEX (VTEX) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $5

> Xylem (XYL) downgraded to Hold from Buy at Stifel; tgt raised to $115

Others:

> Annaly Capital Mgmt (NLY) initiated with a Buy at Jones Trading; tgt $22.50

> Bank of Montreal (BMO) resumed with an Outperform at Credit Suisse

> DZS Inc. (DZSI) initiated with an Outperform at Cowen; tgt $25

> Main Street Capital (MAIN) initiated with a Neutral at UBS; tgt $40

> MasterBrand (MBC) initiated with a Hold at Loop Capital; tgt $9

> NewAmsterdam Pharma (NAMS) initiated with a Buy at Jefferies; tgt $24

> NewAmsterdam Pharma (NAMS) initiated with an Outperform at William Blair

> Schrodinger (SDGR) initiated with a Neutral at Goldman; tgt $23

> Thomson Reuters (TRI) assumed with a Sector Perform at Scotiabank; tgt $126

> VersaBank (VBNK) assumed with an Outperform at Raymond James; tgt $9

> Viridian Therapeutics (VRDN) initiated with an Outperform at Cowen; tgt $45

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Source: Read Full Article